SES AUA 2025: PSA Dynamics from the Phase 3 EMBARK Trial: A Post Hoc Analysis
SES AUA 2025, prostate cancer, EMBARK trial, Leuprolide, biochemical recurrence in prostate cancer.
Related Articles
Unveiling the Molecular Hallmarks of Peyronie’s Disease: A Comprehensive Narrative Review – Beyond the Abstract
Peyronie’s Disease, Molecular Hallmarks of Peyronie’s Disease, tyrosine kinase inhibitor, transforming growth factor-beta (TGF-β), Matrix metalloproteinases (MMP) enzymes, Tissue inhibitors of metalloproteinases proteins (TIMP), pirfenidone,…
Primary Retroperitoneal Lymph Node Dissection for Clinical Stage II Seminoma: A Systematic Review and Meta-Analysis of Safety and Oncological Effectiveness – Beyond the Abstract
Testicular cancer, Testicular germ cell tumor (TGCT), Retroperitoneal Lymph Node Dissection (RPLND), pathological lymph node staging, clinical stage (CS) II seminomatous TGCT.
Up and down the ladder: The latest comings and goings
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with
HHS pursues theory that autism is linked to a toxin — experts are not so sure
HHS Secretary Robert F. Kennedy Jr. declared that the new administration will identify an environmental toxin causing autism in a matter of months, but experts…
How Health Systems are Losing Contact with their Clinicians – The Health Care Blog
Jeff wrote this article for Hospitals & Health Networks in the July 5, 1998 edition. He republished it this week on his substack calling it…
Pharmalittle: We’re reading about FDA layoffs hurting user fee programs, pharma tariffs, and more
The FDA will remove industry representatives from advisory committees and replace them with patients and caregivers
How to think about Trump’s pharma tariffs — before they hit
Even before tariffs hit on the pharma industry, drugmakers are considering ways to try to soften their blow.
Advancing Holmium Laser Enucleation of the Prostate Outcomes Reporting: An Assessment of Patient-Reported Outcomes in the Literature – Beyond the Abstract
Benign prostatic hyperplasia (BPH), lower urinary tract symptoms (LUTS), Holmium Laser Enucleation of the prostate cancer (HoLEP), Advancing Holmium Laser Enucleation, American Urological Association Symptom…
Home health providers want a cut of Medicare Advantage pay hike
Home health companies said the prospect of higher medical supply costs from tariffs and high labor costs are forcing them to play hardball with insurers…
